Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
iTeos Therapeutics, Inc. (ITOS) had Stock-Based Compensation of $29.94M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$35.00M |
|
$-134.41M |
|
-- |
|
$35.00M |
|
$194.53M |
|
$-159.53M |
|
$39.19M |
|
$-120.34M |
|
$-120.34M |
|
$-134.41M |
|
$-134.41M |
|
$-134.41M |
|
$-134.41M |
|
$-159.53M |
|
$-169.81M |
|
40.47M |
|
40.47M |
|
$-3.32 |
|
$-3.32 |
|
| Balance Sheet Financials | |
$509.54M |
|
$4.89M |
|
$177.44M |
|
$686.98M |
|
$40.36M |
|
-- |
|
$56.32M |
|
$96.68M |
|
$590.29M |
|
$590.29M |
|
$590.29M |
|
36.57M |
|
| Cash Flow Statement Financials | |
$-98.18M |
|
$-131.15M |
|
$122.24M |
|
$251.45M |
|
$142.43M |
|
$-109.02M |
|
|
Stock-Based Compensation |
$29.94M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-455.79% |
|
-455.79% |
|
-485.17% |
|
-343.83% |
|
-384.04% |
|
$-99.81M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
9.48 |
|
38.49 |
|
-22.77% |
|
-22.77% |
|
-19.57% |
|
-22.77% |
|
$16.14 |
|
$-2.47 |
|
$-2.43 |
|